The field of DNA microarray data analysis is getting increasingly complicated as scientists develop new array technologies and analysis algorithms, yet accurate introductory information on the subject ...

Transcenta Therapeutics (HKEX: 06628), a global clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, research, development and manufacturing of antibody-based ...

More and more scientists are taking advantage of DNA microarray chip technology to further their research. PubMed can give a rough estimate of the growth and acceptance of this technology; a search ...

Next generation genomics technology is playing a significant role in improving the outcomes of genomic tools used in livestock farming, cultivation of crops, selection of quality seeds with improved ...

The honorees are scheduled to deliver lectures during this year’s meeting in San Diego, CA, which runs from April 17-22.

The SureScan Microarray Scanner is a key component of Agilent’s complete microarray solution. With improved feature resolution, it delivers exceptional flexibility to analyze any microarray ...

Prediabetes may leave a lasting molecular "footprint" on adipose (fat) tissue which appears to make maintaining weight loss ...

A multimillion-pound industry has sprung up promising it can detect sensitivities to certain ingredients with a simple remote finger prick test. But the results can be misleading – and even dangerous ...

Prediabetes may leave a lasting molecular "footprint" on adipose (fat) tissue which appears to make maintaining weight loss after bariatric surgery ...

LuxScan 10K Microarray Scanner is a compact high performance system for microarray imaging and data analysis of DNA, protein and cell arrays. Its advanced systems for optics, signal processing and ...

Kathleen Elison is the co-founder and principal scientist at Terray Therapeutics, where she leads the research and ...

When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fear their firms will lose out in other ...